secwatch.observer — SEC 8-K summary
======================================

Issuer:     Foghorn Therapeutics Inc. (FHTX)
CIK:        0001822462
Form:       8-K
Filed at:   2025-06-17T23:59:59+00:00
Accession:  0001628280-25-031819
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Foghorn Therapeutics stockholders elect four Class II directors, ratify Deloitte as auditor
--------------------------------------------------------------------------------

- Elected Stuart Duty, Neil J. Gallagher, Adrian Gottschalk, and Ian F. Smith as Class II directors for three-year terms.
- Votes for nominees ranged from 30.9M (Ian F. Smith) to 34.6M (Neil J. Gallagher); 8.68M broker non-votes.
- Ratified Deloitte & Touche LLP as independent auditor for FY2025 with 43.34M votes for, 16,978 against.
- Total shares present at meeting: 43,369,822 out of 55,721,340 outstanding; all proposals approved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822462/000162828025031819/0001628280-25-031819-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822462/000162828025031819/fhtx-20250617.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-031819

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer